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Abstract
To maintain dNTP pool homeostasis and preserve genetic integrity of nuclear and mitochondrial genomes, the synthesis and 
degradation of DNA precursors must be precisely regulated. Human all-alpha dCTP pyrophosphatase 1 (DCTPP1) is a dNTP 
pyrophosphatase with high affinity for dCTP and 5′-modified dCTP derivatives, but its contribution to overall nucleotide 
metabolism is controversial. Here, we identify a central role for DCTPP1 in the homeostasis of dCTP, dTTP and dUTP. 
Nucleotide pools and the dUTP/dTTP ratio are severely altered in DCTPP1-deficient cells, which exhibit an accumulation 
of uracil in genomic DNA, the activation of the DNA damage response and both a mitochondrial and nuclear hypermutator 
phenotype. Notably, DNA damage can be reverted by incubation with thymidine, dUTPase overexpression or uracil-DNA 
glycosylase suppression. Moreover, DCTPP1-deficient cells are highly sensitive to down-regulation of nucleoside salvage. 
Our data indicate that DCTPP1 is crucially involved in the provision of dCMP for thymidylate biosynthesis, introducing a 
new player in the regulation of pyrimidine dNTP levels and the maintenance of genomic integrity.
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Introduction
The accuracy of DNA replication is essential for the main-
tenance of genome integrity. The absolute and relative con-
centrations of the four deoxyribonucleoside triphosphates 
(dNTPs) are key determinants of the fidelity of DNA rep-
lication [1, 2]. As a result, an imbalanced dNTP pool can 
strongly promote replication errors [3, 4]. On the other 
hand, low dNTP availability causes mitochondrial and 
chromosomal instability in eukaryotic cells, especially after 
DNA damage is inflicted, since repair mechanisms require 
DNA synthesis [5]. Therefore, a tight control of the biosyn-
thetic and catabolic pathways that regulate dNTPs levels is 
critical, since defects in their regulation originates replica-
tion stress and compromises genome stability [6–8].
Among other activities, the metabolic breakdown of 
nucleotide or nucleosides may involve phosphorylases, 
nucleotidases, NTP pyrophosphatases and triphosphohy-
drolases. In addition, enzymatic hydrolysis of damaged 
nucleotides cleanses the DNA precursor pool by eliminating 
potentially mutagenic modified nucleotides. Such is the case 
of the human enzyme MTH1 responsible for the elimination 
of 8-oxo-dGTP [9]. In this respect, the recently characterized 
human all-α NTP pyrophosphatase DCTPP1 (dCTP pyroph-
osphatase 1) catalyzes the hydrolysis of dCTP into dCMP 
and pyrophosphate, a conversion which has been proposed 
to keep the cellular dCTP pool balanced [10]. DCTPP1 can 
also hydrolyze in vitro C5-modified dNTPs such as 5-halo-
genated, 5-methyl and 5-formyl deoxycytidine, and therefore 
may have an additional ‘house-cleaning’ function. We have 
previously reported that DCTPP1-deficient cells accumulate 
high levels of dCTP and are hypersensitive to exposure to the 
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nucleoside analogs 5-iodo-2′-deoxycytidine and 5-methyl-
2′-deoxycytidine [10]. In addition, DCTPP1 counteracts 
the cytotoxic effect of the antitumoral demethylating agent 
decitabine (5-aza-deoxycytidine) by removing 5-aza-dCTP 
from the nucleotide pool and is being studied as a potential 
drug target to improve decitabine-based chemotherapy [11, 
12]. In contrast with the role initially proposed for DCTPP1, 
a study performed by Song et al. supports the notion that 
the role of the enzyme is to regulate intracellular levels of 
methyl-dCTP, a function that directly impacts on the degree 
of DNA methylation [13]. This surprising observation is in 
conflict with a study performed by Zauri et al. [14], showing 
that due to strict substrate specificity of nucleotide salvage 
enzymes, newly synthesized DNA is protected against the 
incorporation of epigenetically modified forms of cytosine 
that are not present in the dNTP pool.
DCTPP1, which localizes to the nucleus, cytosol and 
mitochondria in human cells [10], is highly expressed in 
embryonic and proliferative tissues with an expanded 
nucleotide pool (Human Protein Atlas, www.prote inatl 
as.org). The enzyme is also up-regulated in multiple human 
carcinomas and cancer stem cells [13, 15, 16]. Together, 
these observations strongly point toward an important role 
of DCTPP1 in the homeostasis of the dNTP pool in highly 
proliferative cells with a great demand for DNA precursors.
In the present study, we examine the role of DCTPP1 in 
controlling pyrimidine nucleotide homeostasis in different 
cell types. We show that strong down-regulation of DCTPP1 
results in an increased dCTP pool, reduced levels of dTTP 
and the appearance of a potentially genotoxic pool of dUTP. 
As a result, DCTPP1-deficient cells are more prone to ura-
cil misincorporation and exhibit an activated DNA damage 
response (DDR), altered cell cycle progression and a muta-
tor phenotype that affects both chromosomal and mitochon-
drial DNA (mtDNA). Furthermore we demonstrate that 
in the absence of DCTPP1, cells are highly dependent on 
nucleoside salvage for provision of dTTP. Taken together, 
our findings support a prominent role for DCTPP1 in dTTP 
de novo synthesis and in the balance of canonical pyrimidine 
nucleotide pools, a metabolic function that is intrinsically 
linked to the preservation of genome integrity. We propose 
that the function of this nucleotidohydrolase should be taken 
into account when studying the underlying causes of dis-
eases involving an imbalance of the dNTP pools and the 
mode of action of anticancer analogs.
Results
Down‑regulation of DCTPP1 expression impairs 
proliferation and perturbs the dNTP pool of MCF‑7 
cells
DCTPP1 is a human NTP pyrophosphohydrolase with 
high specificity in vitro for dCTP [10]. Here, we sought 
to unveil in different cell types the role of the enzyme 
in the homeostasis of canonical nucleotide pools and cell 
viability and how it interrelates to other enzymes involved 
in pyrimidine metabolism. For this purpose, we accom-
plished silencing of DCTPP1 in MCF-7 cells by siRNA 
and analyzed in detail the consequences of this defect. 
DCTPP1 depletion was efficiently attained, 85–95% 
depletion (Fig. 1a) and induced a significant proliferation 
defect (40% growth inhibition) by day 8 post-transfection 
(Fig. 1b) similar to what has been previously described 
[13]. Likewise, cell cycle analysis of DCTPP1-knockdown 
MCF-7 cells revealed an increase in the percentage of cells 
in the G1 phase and a decrease in the proportion of cells in 
S and G2/M, indicating a delay in the progression of G1 to 
S, the latter being the active phase for dNTP biosynthesis 
(Fig. 1c and Supp. Figure 1). Pyrimidine dNTP pools were 
monitored (Fig. 1d) and an expansion of the dCTP pool 
was observed upon enzyme depletion (3.7 pmol/106 con-
trol cells vs 5.5 pmol/106 deficient cells). This result dif-
fers from what has been previously published for MCF-7 
cells by Song et al. [13], who failed to detect an increase 
in the levels of intracellular dCTP. We ignore the reason 
for these differences, although it is possible that subtle 
differences in serum pyrimidine content may influence 
the results. Moreover, while intracellular levels of dGTP 
remained constant, MCF-7 cells depleted of DCTPP1 
exhibited a significant reduction in the intracellular levels 
of dTTP (7.3 pmol/106 control cells vs 6.4 pmol/106 defi-
cient cells) and the appearance of a substantial dUTP pool, 
absent in control cells (1.5 dUTP pmol/106 cells). The 
presence of dUTP in combination with a decreased pool 
of dTTP can be highly mutagenic [17], since most DNA 
polymerases cannot distinguish between thymine and ura-
cil, and the uracil/thymine incorporation ratio depends on 
the relative level of dUTP and dTTP. The ratios obtained 
here for cells lacking DCTPP1 implies that dUTP is incor-
porated instead of dTTP one out of five times, which rep-
resents a high risk of uracil accumulation in DNA. Thus, 
a novel role for DCTPP1 arises from these observations, 
suggesting that it is also involved in the homeostasis of 
other pyrimidine nucleotides.
An increased dUTP/dTTP ratio represents a critical 
factor in the cytotoxicity induced by chemotherapeutic 
agents that target thymidylate synthase (TS) [18]. To 
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investigate whether the depletion of DCTPP1 sensitizes 
to TS inhibitors which further stimulate the expansion of 
the dUTP pool, we determined the effect of 5-fluoro-2′-
deoxyuridine (5-FdUrd) on cell proliferation. As shown 
in Fig. 1e, down-regulation of DCTPP1 led to increased 
toxicity by 5-FdUrd at doses 1 nM and higher, suggest-
ing that DCTPP1-deficient cells are more susceptible to 
chemotherapeutic drugs that promote imbalances of the 
nucleotide pool and alter the dUTP/dTTP ratio.
We next investigated how other enzymes involved in 
pyrimidine nucleotide homeostasis respond to perturba-
tions in DCTPP1 expression and thus may contribute to the 
modifications observed in MCF-7 cells. As shown in Fig. 1f, 
deoxycytidine kinase (dCK), dCMP deaminase (DCTD) 
and dUTPase levels remained unaltered in DCTPP1-defi-
cient cells while the levels of thymidine kinase 1 (TK1), an 
enzyme involved in thymidine (dThd) salvage, were reduced 
by approximately 50%. The decrease in TK1 could be partly 
related to the cell cycle alterations observed in these cells, 
since it is well documented that TK1 is subjected to cell 
cycle regulation. Thus G1 cells, which accumulate in the 
absence of DCTPP1, are largely deprived of TK1 due to a 
degradation process initiated at the end of mitosis by the 
anaphase promoting complex/cyclosome (APC/C) [19].
DCTPP1‑deficient MCF‑7 cells exhibit increased 
uracil misincorporation and an activation 
of the DNA damage response
The elevated dUTP/dTTP ratio observed in cells devoid 
of DCTPP1 represents a substantial risk for uracil misin-
corporation into DNA and hence of genotoxic damage. We 
therefore assessed the presence of uracil in genomic DNA 
using a qPCR assay that utilizes two DNA polymerases 
with different capacity to replicate through uracil [20]. The 
difference in product formation gives an estimation of the 
uracil content in the DNA, yet the quantification is relative, 
as a zero must be established for the control sample. Nota-
bly, the uracil content of genomic DNA extracted from 
DCTPP1-silenced MCF-7 cells was significantly enhanced 
with regard to control siRNA-transfected cells, revealing 
Fig. 1  DCTPP1 depletion 
impairs proliferation and 
alters the composition of the 
dNTP pool of MCF-7 cells. 
a Western blot analysis of 
MCF-7 cells transfected with 
DCTPP1 and control (siCtrl) 
siRNAs. Anti-α-tubulin was 
used to normalize protein levels. 
The image was cropped and 
edited for easier comparison. 
Values are mean ± SD (n ≥ 3). 
b Proliferation curve of MCF-7 
cells transfected with DCTPP1 
or control siRNAs. Values are 
mean ± SD (n ≥ 3). c Cell cycle 
profile of DCTPP1-siRNA-
transfected cells. Values are 
mean ± SD (n ≥ 3). d Intracel-
lular dNTP pool determina-
tion in DCTPP1-deficient 
cells. Values are mean ± SD 
(n ≥ 3). e Down-regulation of 
DCTPP1 sensitizes cells to 
5-FdUrd. MCF-7 cells (siCtrl 
and siDCTPP1) were exposed 
to increasing concentrations 
of 5-FdUrd for 24 h. The plot 
represents the relative popula-
tion doubling (RPD) (± SD) of 
two independent experiments. f 
Western blot analysis of pyrimi-
dine metabolism enzymes in 
DCTPP1-silenced cells. Anti-
α-tubulin was used to normal-
ize protein levels. Values are 
mean ± SD (n ≥ 3)
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a preferential accumulation of uracil in DCTPP1-depleted 
cells (186 uracils/million bases) (Fig. 2a).
Having demonstrated the modifications in base compo-
sition, we proceeded to evaluate the activation of the DNA 
damage response through assessment of γ-phosphorylation 
of the histone H2AX (H2AX phosphoserine-139), a hall-
mark of the cellular response to DNA double-strand 
breaks  (DSBs). A significant twofold increase of the 
percentage of γH2AX-positive cells was detected when 
DCTPP1 expression was suppressed for 8 days (9.4% vs 
4.9%), thus indicating the specific occurrence of DNA 
lesions in DCTPP1-deficient cells (Fig. 2b). To examine 
whether H2AX phosphorylation occurs specifically in cells 
performing DNA synthesis which are therefore suscep-
tible to DSB formation, γH2AX foci were quantified by 
previous EdU-labeling of S-phase cells (Fig. 2b). Thus, 
when quantification was restricted to MCF-7 cells in the 
S-phase, an increased proportion of foci-containing cells 
was found in the absence of DCTPP1 (12.6% in siDCTPP1 
vs 5.7% in siControl transfected cells). However, the num-
ber of γH2AX-positive cells in S-phase only represents a 
minor fraction of the total amount, thus suggesting that 
other mechanisms are involved in phosphorylation of 
H2AX.
Other key components of the DDR, the serine/threonine 
kinases Chk1 and Chk2, were also examined. As shown in 
Fig. 2c, DCTPP1 silencing specifically promotes the phos-
phorylation of Chk1, but not of Chk2 which is undetect-
able in MCF-7 cells. Furthermore, it has been previously 
described that replication stress causes chromosomal insta-
bility during mitosis [21]. Mitotic DCTPP1-depleted cells 
presented an increased percentage of anaphase bridges in 
comparison to control cells (14.8% vs 8.3% respectively) 
(Fig. 2d). All these observations together suggest the for-
mation of double-strand breaks as one of the potential DNA 
lesions induced as a consequence of DCTPP1 depletion and 
reinforce the importance of DCTPP1 in maintaining genome 
stability.
Modulation of the dUTP/dTTP ratio reduces 
genomic instability
Considering that uracil misincorporation might be the initial 
DNA damage that leads to the induction of γH2AX foci, 
we hypothesized that histone phosphorylation might be 
Fig. 2  Down-regulation of DCTPP1 induces DNA damage in MCF-7 
cells. a Determination of uracil in genomic DNA of MCF-7 cells 
transfected with control or DCTPP1 siRNAs. Values are mean ± SD 
(n ≥ 3). b Immunofluorescence (IF) staining of γH2AX foci. Left 
panel, percentage of γH2AX-positive cells in total or S-phase popula-
tions after transfection with control or DCTPP1 siRNAs. Right panel, 
representative images of γH2AX staining. γH2AX-positive cells (≥ 5 
foci/cell) were scored out of 100 cells per experiment (n = 3). c West-
ern blot analysis of Chk1 and Chk2 phosphorylation in DCTPP1-
depleted cells. Anti-actin was used to normalize protein levels. d 
Left panel, percentage of anaphase bridges in DCTPP1-silenced 
cells. Cells were synchronized for 18 h with nocodazole, released for 
90 min and then fixed for DAPI staining. 100 mitoses were counted 
in each experiment (n = 3). Right panels, representative images of an 
anaphase bridge and a normal anaphase. Unless specified, all deter-
minations were carried out at day 8 post-transfection. Scale bars indi-
cate 10 μm
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prevented by restoring the normal dUTP/dTTP ratio. Thus, 
cells transfected with control or DCTPP1 siRNA were cul-
tured for 24 h in the presence of 5 μM of dThd before γH2AX 
analysis. The rationale behind this metabolic approach is that 
phosphorylation of thymidine via TK1 expands the synthesis 
of dTTP and restores an adequate dUTP/dTTP ratio. The 
incubation with dThd significantly decreased the percent-
age of γH2AX-positive cells in DCTPP1-knockdown cells 
(from 14.5% to 6.8% positive cells) indicating a cause–effect 
relationship between the dUTP/dTTP ratio and the levels 
of H2AX phosphorylation (Fig. 3a). Additionally, the cell 
growth delay induced by siRNA-mediated DCTPP1 silenc-
ing was reverted in the presence of thymidine (Fig. 3b).
To further investigate the implication of a high dUTP/
dTTP ratio in genomic instability, human dUTPase was 
overexpressed in DCTPP1-silenced cells. Thus, cells previ-
ously transfected with either a control or a DCTPP1-siRNA, 
were retransfected with empty pcDNA or pcDNA-dUTPase 
(pcDNA-DUT) vectors. Indeed, the overexpression of dUT-
Pase decreased the formation of γH2AX foci in a DCTPP1-
deficient background (from 19.5 to 13% positive cells) 
(Fig. 3c) to levels very similar to those found in control cells 
transfected with pcDNA or with pcDNA-DUT (12.2% and 
12.9%, respectively). The data support the hypothesis that 
the incorporation of dUTP during DNA replication is likely 
behind the activation of the DDR, a process than can be 
prevented by restoring an adequate dUTP/dTTP ratio either 
by dThd supplementation or by elimination of dUTP from 
the cellular pool.
Several studies have reported that the loss of uracil gly-
cosylase activity (UNG) contributes to alleviate the delete-
rious phenotypes associated with increased dUTP/dTTP 
ratios [22–24]. We therefore set out to investigate the role 
of uracil-DNA glycosylase in DCTPP1-deficient MCF-7 
cells. Strong down-regulation of UNG partially restored the 
proliferation of DCTPP1-silenced cells (from approximately 
60–80% at day 8 post-transfection) (Fig. 3d, e). Moreover, 
the phosphorylation of H2AX was entirely abrogated upon 
UNG depletion (Fig. 3f). These results indicate that ura-
cil removal and the subsequent generation of abasic (AP) 
sites appear to be the main source for the DSBs induced by 
DCTPP1 knockdown.
Functional characterization of a DCTPP1 knockout 
HAP1 cell line
While the down-regulation of DCTPP1 has profound 
consequences on cell cycle progression, nucleotide pools 
Fig. 3  DNA damage response is abrogated by thymidine supplemen-
tation, dUTPase overexpression or uracil-DNA glycosylase suppres-
sion. a Quantification of γH2AX foci after thymidine (dThd) supple-
mentation of DCTPP1 and control siRNA-transfected cells. At day 7 
post-transfection, cells were supplemented with dThd (5 μM), incu-
bated for 24 h and fixed for IF staining. Values are mean ± SD (n ≥ 3). 
b Thymidine reverts the proliferation defect induced by DCTPP1 
silencing. At day 5 post-transfection, control and DCTPP1-silenced 
cells were supplemented with dThd (5  μM) and cell growth moni-
tored over a 4 day period. c Quantification of γH2AX foci after 48 h 
under dUTPase overexpression. At day 6 post-transfection, cells were 
retransfected with pcDNA-DUT or empty pcDNA plasmid. Values 
are mean ± SD (n ≥ 3). d Western blot analysis of MCF-7 cells at day 
4 post-transfection with UNG and control (siCtrl) siRNAs. Anti-α-
tubulin was used to normalize protein levels. e Proliferation curves of 
MCF-7 cells transfected with DCTPP1, UNG or control siRNAs. Val-
ues are mean ± SD (n ≥ 3). f Quantification of γH2AX foci after UNG 
silencing of DCTPP1-knockdown cells. Transfection with siUNG was 
carried out at day 4 post-transfection with siDCTPP1 or siCtrl and 
analyzed at day 8. Values are mean ± SD (n ≥ 3). Unless specified, all 
determinations were carried out at day 8 post-transfection
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and DNA integrity in MCF-7 cells, a bona fide DCTPP1-
knockout (DCTPP1-KO) cell line derived from the HAP1 
cell line is readily available (Horizon Discovery). HAP1 
is a near haploid human cell line that was derived from 
the male chronic myelogenous leukemia (CML) cell line 
KBM-7 [25]. To monitor the impact of the absence of 
DCTPP1 and identify factors contributing to tolerance to 
the lack of the enzyme, a viable clone harboring a 13 bp 
deletion in exon 2 of the DCTPP1 gene generated using 
the CRISPR/Cas9 technology was subjected to a func-
tional characterization. These cells present a truncated 
form of DCTPP1 of approximately 10 kDa (Fig. 4a, b). 
Of the 93 amino acids of the truncated protein, only 41 
correspond to the canonical sequence, the rest are aber-
rant amino acids (Fig. 4b). These cells lack a functional 
DCTPP1, since the resultant protein contains only one of 
the seven residues implicated in catalysis [26]. In contrast 
to MCF-7 cells, a deficiency in DCTPP1 does not affect 
either proliferation or cell cycle progression (Fig. 4c, d). 
A number of studies have reported phenotypic differences 
between knockout and knockdown approaches in different 
model organisms [27]. This phenotypic difference could 
be attributed to compensatory mechanisms triggered 
only after gene inactivation and clone selection. Indeed 
unexpectedly, DCTPP1 inactivation in HAP1 cells did 
not induce an expansion of the dCTP pool as described 
above for MCF-7. Here, the level of dCTP was estimated 
to be 2.6 pmol and 2.9 pmol (per  106 cells) in control and 
DCTPP1-KO cells, respectively (Fig. 4e). In the latter, 
however, the pool of dTTP was again significantly reduced 
from 11.8 pmol/106 to 7.4 pmol/106, while a dUTP pool 
with potential genotoxic consequences was exclusively 
detected in deficient cells (0.25 pmol/106 cells). No differ-
ences in the pool of dGTP were observed between HAP1 
WT and DCTPP1-KO cell lines.
Changes in the expression of other key enzymes of 
pyrimidine metabolism which may be modulated in 
response to the inactivation of DCTPP1 were not detected 
(Fig. 4f). However, other types of enzymatic regulation 
can be responsible for the control of the dCTP pool in 
the absence of DCTPP1. On the other hand, TK1 levels 
were similar in both genetic backgrounds implying that it 
appears to be the loss of DCTPP1 and not differences in 
thymidine salvage, which was the major factor responsible 
for the decrease in dTTP. The results point toward a cen-
tral role of DCTPP1 in the formation of dCMP for dTMP 
biosynthesis.
Fig. 4  DCTPP1-knockout cells exhibit normal proliferation in spite 
of an imbalanced nucleotide pool. a Western blot showing the pres-
ence of a truncated non-functional DCTPP1 in the knockout cell line. 
b Immunofluorescence analysis showing the mitochondrial localiza-
tion of the truncated DCTPP1 in DCTPP1-KO cells. Below, linear 
representations of the domains present in wild-type DCTPP1 and the 
truncated form resulting from CRISPR/Cas9 editing. c Proliferation 
curves of HAP1 WT and DCTPP1-KO cell lines. d Cell cycle analy-
sis of DCTPP1-KO cells by FACS. e Determination of the pyrimi-
dine dNTP pools. Values are mean ± SD (n ≥ 3). f Comparison by 
western blot of the expression levels of different pyrimidine metabo-
lism enzymes in parental HAP1 WT and DCTPP1-KO cells. Anti-α-
tubulin was used to normalize protein levels. Results are mean ± SD 
(n ≥ 3). Scale bars indicate 10 μm
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The activation of the DNA damage response 
upon DCTPP1 inactivation can be reverted 
by the expansion of the dTTP pool or defects 
in uracil excision
Having established an expansion of the dUTP pool also in 
DCTPP1-KO cells, the relative uracil content was quanti-
fied again in control and DCTPP1-knockout genomic DNA 
samples (Fig. 5a). In correlation with the higher dUTP/
dTTP ratio observed in DCTPP1-deficient cells, their DNA 
accumulates a higher amount of uracil (622 uracil per mil-
lion bases more than parental cells). Consistently with 
their elevated genetic instability, HAP1 cells have easily 
detectable endogenous levels of pChk1, which appear suf-
ficient to cope with further DNA damage resulting from 
DCTPP1 inactivation. pChk2 levels were slightly increased 
in DCTPP1-KO cells, suggesting that Chk2 phosphorylation 
may have a minor role in the DDR (Fig. 5b). On the other 
hand, the percentage of γH2AX-positive cells was signifi-
cantly enhanced as a consequence of DCTPP1 inactivation: 
from 8.2 to 35.9% (data from total cell population) and from 
7.6 to 22.2%, when considering only the S-phase population 
(Fig. 5c). When referred to the whole cell population, the 
total cells in the S-phase represent 4.5% and 12.9% respec-
tively. Therefore, around one-third of γH2AX foci associ-
ated with DCTPP1 inactivation (12.9% out of 35.9%) were 
observed in S-phase cells and may be the result of slow or 
inefficient DNA repair during DNA replication.
To restore the dUTP/dTTP ratio, HAP1 WT and 
DCTPP1-KO cells were also treated with 1 µM or 5 µM 
of thymidine for 24 h before γH2AX foci evaluation. At 
these dThd concentrations, a thymidine block is not reached 
in HAP1 cells (Supp. Figure 2). In HAP1 WT cells, the 
percentage of foci was not significantly affected by the 
Fig. 5  HAP1 cells defective in DCTPP1 present increased DNA dam-
age. a Detection of uracil in genomic DNA of DCTPP1-KO cells. 
Genomic DNA isolated from HAP1 WT cells was used as a refer-
ence. b Western blot analysis of Chk1 and Chk2 phosphorylation. 
Anti-actin was used to normalize protein levels. c Left panel, per-
centage plots of γH2AX-positive HAP1 WT and DCTPP1-KO cells 
in total or S-phase populations. γH2AX-positive cells were scored 
out of 100 cells per experiment (n = 3). Right panel, representative 
images of γH2AX staining. Scale bars indicate 10 µm. d Determina-
tion of γH2AX foci after incubation of HAP1 WT and DCTPP1-KO 
cells with 1 or 5 μM of thymidine (dThd). e Western blot analysis of 
HAP1 cells at day 4 post-transfection with UNG and control (siCtrl) 
siRNAs. Anti-α-tubulin was used to normalize protein levels. f Quan-
tification of γH2AX foci after UNG silencing in DCTPP1-knockout 
cells. Values are mean ± SD (n ≥ 3)
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treatment with thymidine; in contrast, when DCTPP1-KO 
cells were supplemented with 1 µM or 5 µM dThd, the per-
centage of foci decreased from 34.9 to 26.3% and 16.8%, 
respectively, supporting the relationship between a high 
dUTP/dTTP ratio and H2AX phosphorylation as observed 
in MCF-7 cells (Fig. 5d). Likewise, silencing of UNG by 
siRNA fully reverted the H2AX phosphorylation observed in 
DCTPP1-KO cells (Fig. 5e, f), further reinforcing the notion 
that uracil repair intermediates are responsible for the activa-
tion of DDR in the absence of DCTPP1.
DCTPP1‑KO cells exhibit a hypermutator phenotype
The data presented suggest that the DCTPP1 mutant has to 
cope with severe genetic damage as a result of the alterations 
of the nucleotide pool. We have shown that cells defective in 
DCTPP1 are characterized by high amounts of uracil-DNA 
damage, increased anaphase bridge formation, cell cycle 
defects and the activation of DDR mechanisms. Hence, this 
mutant was expected to exhibit a spontaneous mutator phe-
notype. The haploid HAP1 cell line harbors only one copy of 
the hypoxanthine phosphoribosyltransferase (HPRT) gene, 
which can be used as a forward mutagenesis marker [28]. 
Under the conditions established, the spontaneous muta-
tion frequency of DCTPP1-KO cells was 3.14 × 10−5, 4.5-
fold higher than the value estimated for HAP1 WT cells 
(6.99 × 10−6) (Fig. 6a).
If the perturbation of the dNTP pool is at the origin of 
the mutator phenotype of DCTPP1-deficient cells, it should 
be reproduced in mitochondrial DNA, since its synthesis is 
greatly dependent on the cytosolic dNTP pool [29]. Besides, 
DCTPP1 is also present in the mitochondria and the mito-
chondrial dNTP pool might be disturbed in knockout cells. 
To assess mtDNA integrity, mutations at the 16S riboso-
mal RNA subunit encoded by the mtDNA were selected by 
resistance to chloramphenicol (CAP). Figure 6b shows the 
percentage of CAP-resistant colonies in WT and DCTPP1-
KO cells lines. DCTPP1 deficiency strongly increased 
mtDNA mutagenesis from 10.7 to 21.2%. It is possible that 
DCTPP1 performs a specific mitochondrial role with an 
impact on mtDNA stability and that its mitochondrial activ-
ity is required for the homeostasis of the nucleotide pool in 
this compartment.
Contribution of DCTPP1 to de novo dTTP synthesis 
in HAP1 cells
The reduction of the dTTP pool upon DCTPP1 depletion 
indicates that the enzyme contributes in a relevant manner 
to de novo synthesis of dTTP. We hypothesized that this 
function is accomplished by providing dCMP which can be 
converted into dTMP in two consecutive reactions catalyzed 
by dCMP deaminase and thymidylate synthase activities. We 
therefore anticipated that in the absence of DCTPP1, thymi-
dine salvage by TK1 and also deoxycytidine salvage by dCK 
might play a critical role in the synthesis and homeostasis 
of dTTP (Fig. 7a).
To address these questions, thymidine and deoxycytidine 
salvage were inhibited by siRNA. HAP1 WT and DCTPP1-
KO cells were transiently transfected with either siRNA-TK1 
or siRNA-dCK, and the loss of enzyme expression was veri-
fied by western blot. TK1 and dCK proteins were greatly 
decreased and the levels remained low until the end of the 
experiment (Fig. 7b, c). DCTPP1 knockout cells were hyper-
sensitive to both TK1 and dCK depletion, with profound 
defects in cell growth (50–60% inhibition) at day 3 post-
transfection. Conversely, TK1 or dCK silencing in HAP1 
WT cells did not have a significant effect compared to con-
trol siRNA-transfected cells.
The relevance of dCMP deaminase in cell proliferation 
was also evaluated. HAP1 WT and DCTPP1-KO cells both 
present growth defects, yet are both equally sensitive to 
Fig. 6  Nuclear and mitochondrial genomes from DCTPP1-deficient 
cells exhibit increased mutation frequencies. a Determination of 
hypoxanthine phosphoribosyltransferase (HPRT) gene mutation fre-
quency. Cells were grown for 15 days and then treated with 6-thio-
guanine to select  HPRT− mutants. Three independent experiments are 
represented in the plot. b Chloramphenicol (CAP) resistance assay. 
The percentage of CAP-resistant colonies was calculated relative to 
the number of total viable colonies grown in the absence of CAP. Val-
ues are mean ± SD (n ≥ 3)
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DCTD depletion by siRNA (Fig. 7d) suggesting that dCMP 
deamination is a crucial step in the provision of thymidylate 
and eventually dTTP. These results further support an impor-
tant and novel role for DCTPP1 in the maintenance of the 
dTTP pool, such that in the absence of deoxycytidine or thy-
midine salvage, DCTPP1 becomes essential for cell viability.
Fig. 7  Nucleoside salvage is 
required for normal prolifera-
tion in the absence of DCTPP1. 
a Schematic diagram of the 
pyrimidine metabolic pathway 
in humans. In addition to its 
role in dCTP homeostasis, 
DCTPP1 is involved in the de 
novo synthesis of dTTP. The 
shaded blue arrow indicates 
the proposed route for the 
conversion of excess dCTP into 
dTTP. The DCTPP1 reaction 
product, dCMP, is converted to 
thymidylate (dTMP) through 
the consecutive reactions of 
dCMP deaminase (DCTD) and 
thymidylate synthase (TS). 
Red boxes: de novo synthesis 
enzymes; green boxes: enzymes 
involved in deoxynucleoside 
salvage; yellow boxes: enzymes 
involved in dTMP biosynthesis 
via dCMP. b Effect of thymi-
dine kinase 1 (TK1) silencing 
on cell growth. Left panel, 
growth curve of HAP1 WT and 
DCTPP1-KO cells transfected 
with control or TK1 siRNAs. 
Right panel, analysis of protein 
levels at day 4 post-transfection. 
c Impact of deoxycytidine 
kinase (dCK) silencing on cell 
growth. Left panel, growth 
curve of HAP1 WT and 
DCTPP1-KO cells transfected 
with control or dCK siRNAs. 
Right panel, western blot analy-
sis at day 4 post-transfection. 
d Down-regulation of dCMP 
deaminase (DCTD) in the pres-
ence or absence of DCTPP1. 
Left panel, growth curve of 
HAP1 WT and DCTPP1-KO 
cells transfected with control 
or DCTD siRNAs. Right panel, 
western blot analysis at day 4 
post-transfection
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Nucleotide pools are strongly dependent 
on DCTPP1 and pyrimidine salvage
The cell cycle was analyzed in TK1-silenced cells at 
day 2 post-transfection (Fig. 8a). In both, wild-type and 
DCTPP1-deficient backgrounds, the absence of TK1 
caused a strong decrease in the number of cells in S-phase 
and simultaneous increases in both G1 and G2/M phases. 
These cell cycle anomalies induced by TK1 silencing, in 
particular the decrease in S-phase cells, were more pro-
nounced in a DCTPP1-KO genetic background than in 
HAP1 WT cells (6.6% vs 18%, respectively), thus explain-
ing their different proliferation rates.
The dNTP pool composition was also determined at day 
2 after TK1 depletion (Fig. 8b). Again, no expansion of the 
dCTP pool was observed in DCTPP1-KO cells transfected 
with a siRNA control. Upon TK1 depletion, the dTTP pool 
in HAP1 WT cells was significantly reduced (from 5.0 to 
2.6 pmol/106 cells), reaching levels comparable to those 
of DCTPP1-KO cells (2.5 pmol/106 cells). However, when 
TK1 was silenced in DCTPP1-KO cells, the dTTP levels 
were further severely diminished (1.3 pmol/106 cells), evi-
dencing the participation of both enzymes in the synthesis 
of dTTP.
The uracil levels in DNA from cells devoid of TK1 and 
DCTPP1 were high, but still comparable to those of cells 
with single enzyme defects in DCTPP1 or TK1 (Fig. 8c). 
On the other hand, the percentage of γH2AX foci in paren-
tal cells increased from 9.8% to 25.4% after 4 days of TK1 
depletion, while DCTPP1-deficient cells showed massive 
immunostaining with the antibody (30–40% positive cells) 
before and after TK1 silencing (Fig. 8d). TK1 depletion 
in DCTPP1-KO cells does not result in increased DNA 
damage (Fig. 8c, d), although the decrease in the dUTP 
pool together with the reduction of the number of cells 
undergoing replication during the S-phase would minimize 
dUTP incorporation, and therefore may account for this 
latter observation.
Fig. 8  Effect of TK1 depletion on DCTPP1-knockout cells. a Cell 
cycle profile of HAP1 WT and DCTPP1-KO cells transfected with 
control or TK1 siRNAs at day 2 post-transfection. b Determination 
of the pyrimidine dNTP pools at day 2 post-transfection in HAP1 WT 
and DCTPP1-KO cell lines transfected with control or TK1 siRNAs. 
c Uracil in genomic DNA of HAP1 WT and DCTPP1-KO cells trans-
fected with control or TK1 siRNAs at day 2 post-transfection. DNA 
isolated from HAP1 WT cells transfected with control siRNA was 
used as a reference. d Quantification of γH2AX foci. Percentage of 
γH2AX-positive cells was determined at days 2 and 4 post-transfec-
tion of HAP1 WT and DCTPP1-KO cells with control or TK1 siR-
NAs. γH2AX-positive cells were scored out of 100 cells per experi-
ment (n = 3). All values are mean ± SD (n ≥ 3)
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Discussion
Here, the metabolic function of DCTPP1 was studied by 
using two different reverse genetics approaches, transient 
gene silencing and CRISPR/Cas9-based gene targeting, 
in two established mammalian cell models: breast can-
cer MCF-7 cells and the KBM-7-derived HAP1 cell line, 
respectively. We observed that DCTPP1-knocked down 
MCF-7 cells showed an expanded dCTP pool, support-
ing a major role for DCTPP1 as a dCTP hydrolase. This 
observation contrasts with the data of Song et al. [13], who 
failed to detect changes in the pool of canonical nucleo-
tides in the same cell type. By contrast, the level of this 
nucleotide remained unaffected in knockout HAP1 cells, 
where it is possible that a hitherto unknown compensa-
tory response is induced to regulate dCTP levels. Con-
ceivable mechanisms could include post-translational or 
allosteric regulation of SAMHD1 triphosphohydrolase 
[30, 31]. Indeed, phosphorylation of SAMHD1 threonine 
592 appears to increase its dCTP hydrolase activity [32] 
and might compensate for the loss of DCTPP1. Moreover, 
modulation of CDP reduction, CDP or CTP biosynthesis 
could contribute to dCTP homeostasis in knockout cells.
Further analysis of the dNTP pool composition revealed 
a substantial reduction of dTTP and the presence of signifi-
cant amounts of dUTP in both experimental models. These 
data suggest that DCTPP1 is not only implicated in keeping 
a balanced pool of dCTP, but also crucially contributes to 
the synthesis of dTTP. In support of this additional function 
for DCTPP1, we have shown that diminishing of nucleo-
side salvage by dCK or TK1 silencing reduces dTTP below 
critical levels and impairs proliferation of DCTPP1-deficient 
cells, indicating that in the absence of deoxycytidine or thy-
midine salvage, DCTPP1 becomes essential for the provi-
sion of thymidylate. In a previous study performed in HeLa 
and MRC-5 cells, down-regulation of DCTPP1 resulted in 
an expansion of the dCTP pool, while the levels of dTTP 
remained unchanged [10]. It is possible that the relative con-
tribution of the two pathways to dTMP formation accounts 
for the differential growth phenotype and dNTP levels in 
different cell types.
A notable consequence of DCTPP1 depletion was ura-
cil accumulation in DNA, activation of the DNA repair 
response and a hypermutator phenotype. Our results indicate 
that an elevated dUTP/dTTP ratio is the major cause of these 
observations. Consistently, we have shown that restoration 
of an adequate dUTP/dTTP ratio in DCTPP1-deficient cells, 
either by exogenous supplementation of thymidine or by 
up-regulation of dUTPase, reduced extensive genome dam-
age marked by persistent γH2AX foci. Uncontrolled uracil 
incorporation provokes chromosomal instability and harmful 
effects in both prokaryotic and eukaryotic cells [33] mostly 
in an indirect manner, due to preferential misincorporation 
of dAMP or dCMP opposite the abasic site intermediate 
generated by the base excision repair pathway responsible 
for uracil elimination [23, 34]. Moreover, excessive dUTP 
incorporation leads to futile cycles of excision and synthe-
sis that may eventually engender lethal DNA fragmentation 
due to replication fork collapse at uracil-excision intermedi-
ates [35]. In agreement with this model, a recent study has 
shown that an elevated uracil incorporation, promoted by the 
combination of high expression levels of the ribonucleotide 
reductase (RNR) subunit R2 and low levels of dUTPase, 
is  related to increased accumulation of double-stranded 
breaks in AT-rich common fragile sites and a higher number 
of chromosomal fragile sites associated anaphase bridges 
[36].
In addition to restoring an adequate dUTP/dTTP ratio 
through thymidine supplementation or dUTPase overex-
pression, suppression of the main uracil glycosylase activ-
ity also alleviated the genotoxic phenotype associated with 
DCTPP1 depletion, thus indicating that uracil in DNA and 
the subsequent formation of AP sites is a major factor in the 
activation of the DDR. On the other hand, a detailed cell 
cycle analysis of histone H2AX phosphorylation revealed 
that a significant portion of the γH2AX-positive cells were 
outside S-phase and therefore DSBs in these cells were not 
caused by the collapse of the replication fork. In this sense, a 
number of studies have reported that the nucleotide excision 
repair (NER) activates the DNA damage response (includ-
ing H2AX phosphorylation) in non-S-phase cells [37–39]. 
Indeed, although AP sites are not helix distorting lesions, 
they can be recognized and repaired by NER [40–42]. Thus, 
while DSBs may arise from multiple pathways, involving or 
not DNA replication, the excision of uracil by UNG and the 
generation of AP sites, if not repaired efficiently, may lead 
to further genotoxic damage.
The association of pyrimidine pool disequilibrium with 
replication stress and genome instability has been exten-
sively documented. Specifically, fission yeast dCMP deami-
nase mutants exhibit a phenotype that is clearly reminis-
cent of the one described for MCF-7 cells after depletion 
of DCTPP1, consisting in perturbed dCTP (elevated) and 
dTTP (decreased) pools, activation of genome integrity 
checkpoints, impaired DNA replication and defective growth 
[43]. Moreover, cytidine deaminase (CDA) down-regulation 
and elevated dCTP pools have been associated to Bloom 
syndrome, a genetic rare disease produced by mutations in 
the BLM gene and characterized by defective DNA repli-
cation, high rates of sister chromatid exchange, a dramatic 
increase in the number of chromatin bridges and predisposi-
tion to cancer [44].
Here, we show that DCTPP1-depleted cells are hyper-
sensitive to inhibition of de novo dTMP biosynthesis, yet 
several studies also point toward the pathophysiological 
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relevance of DCTPP1. Thus, observations have been 
reported that suggest that DCTPP1 is under MYC regulation. 
For instance, stauprimide treatment, which suppresses MYC 
transcription in various cancer cell lines, induces selective 
down-regulation of MYC target genes including DCTPP1 
[45]. DCTPP1 appears to be up-regulated in liver stem cells 
overexpressing MYC [46]. Overexpression of DCTPP1 has 
been also described in multiple tumors [15] and has been 
identified as a poor prognosis marker in gastric, breast and 
prostate cancer [13, 16, 47]. We propose that DCTPP1 
should now also be considered as a major factor contrib-
uting to pyrimidine homeostasis. Remarkably, depletion of 
the enzyme not only increased the spontaneous mutation 
frequency of DCTPP1-KO cells, but also compromised the 
mtDNA integrity. Understanding cellular mechanisms for 
the preservation of mtDNA integrity is of paramount impor-
tance, because it can provide targets for clinical interven-
tions aimed at prevention and treatment of human diseases 
related to mutations in mtDNA.
In summary, our results shed new light on the mecha-
nisms that regulate dNTP homeostasis. We have identified 
DCTPP1 as a crucial element in the enzymatic network 
involved in de novo synthesis of pyrimidines that provides 
a novel pathway for the conversion of dCTP into dTTP. 
DCTPP1 initiates this route by generating dCMP that is 
subsequently channeled to the synthesis of thymidylate 
(Fig. 7a). A singular feature of nucleotide metabolism is the 
duplication of pathways; thus, we have seen upon inhibition 
of DCTPP1 that cells are highly dependent on nucleoside 
salvage. We have also established that a defect in DCTPP1 
causes imbalance of pyrimidine nucleotide pools, a meta-
bolic function that is intrinsically linked to the preserva-
tion of genome integrity. These observations are in accord-
ance with recent studies showing that precise regulation of 
dNTP catabolism is a prominent factor to prevent replication 
stress, genome damage and cell death [9, 36]. Modulation of 
DCTPP1 activity might be a valuable tool to disrupt de novo 
synthesis and nucleotide homeostasis in highly proliferative 
cells with a great demand for DNA precursors such as cancer 
cells. Its role in mutations arising during processes such as 
neurodegeneration or aging may also be considered. In addi-
tion, previous work has shown that inhibition of DCTPP1 
may improve the action of certain pyrimidine nucleoside 
analogs used as anticancer drugs [11, 12, 48, 49]. Finally, 
its role in the maintenance of mtDNA integrity may provide 
a new avenue for therapies of diseases related to nucleotide 
supply and balance in this organelle. Future studies will 
demonstrate the clinical utility of these approaches.
Materials and methods
Cell lines and siRNA transfections
The haploid cell lines HAP1 WT and HAP1 DCTPP1-KO 
(Catalog ID HZGHC003248c012) were purchased from 
Horizon Discovery. The HAP1 DCTPP1-KO cell line 
was genetically modified by CRISPR/Cas9 and contains a 
13 bp deletion in exon 2. Wild-type and knockout cell lines 
were maintained in Iscove’s modified Dulbecco’s medium 
(IMDM) (Life Technologies) supplemented with 10% fetal 
bovine serum (FBS) (Life Technologies), 100 units/mL 
penicillin and 100 µg/mL streptomycin (Life Technologies). 
MCF-7 cells (HTB-22, ATCC ®) were cultured in Eagle’s 
minimum essential medium (MEM) (Life Technologies) 
supplemented with 10% FBS, 100 units/mL penicillin and 
100 µg/mL streptomycin.
Transient silencing was carried out with siRNA oligonu-
cleotide pools (ON-TARGETplus smart pool, Dharmacon) 
specific for DCTPP1 [10], TK1, dCK, DCTD and UNG. 
TK1 was targeted with a siRNA pool with the following 
sequences: 5′- GGG CCG AUG UUC UCA GGA A-3′; 5′-GCA 
UUA ACC UGC CCA CUG U-3′; 5′-GCA CAG AGU UGA 
UGA GAC G-3′ and 5′-CAA AGA CAC UCG CUA CAG C-3′. 
The siRNA pool directed against dCK consisted of the fol-
lowing sequences: 5′-CCA GAG ACA UGC UUA CAU A-3′; 
5′-AAA GCU GGC UCC UGC AUA G-3′; 5′-UAU CAA GAC 
UGG CAU GAC U-3′ and 5′-GGA AUG UUC UUC AGA UGA 
U-3′. The siRNAs directed against DCTD consisted of the 
following sequences: 5′-GCA AGA AAC GGG ACG ACU A-3′; 
5′-CCU UGU AAU GAA UGC GUA -3′; 5′-UCA AUU AAC 
AGC AGA CCG A-3′ and 5′-GGG GUG ACA UUC CGG AAA 
U-3′. To target UNG mRNA the siRNA pool included the 
following siRNAs: 5′-UUA UCA AGC UAA UGG GAU U-3′; 
5′-GAA CUC GAA UGG CCU UGU U-3′; 5′-GAA GCG GCA 
CCA UGU ACU A-3′ and 5′-UAU AGA GGG UUC UUU GGA 
U-3′. The negative control comprised four non-targeting 
siRNA oligonucleotides (ON-TARGETplus non-target-
ing pool, Dharmacon). Transfection was performed using 
 jetPRIME® (Polyplus) for HAP1 cells and Lipofectamine 
2000 (Life Technologies) for MCF-7 cells according to the 
manufacturer´s instructions.
Proliferation assays
To perform the proliferation assays, cells were seeded into 
96-well plates (2 × 103 cells/well) 24 h after transfection. 
Every 24 h, cells were incubated with 20 µL of Resazurin 
(1.1 mg/mL (Sigma-Aldrich) in the dark for 2 h at 37 °C. 
Cell growth was determined by measuring the fluorescence 
at 570 nm (excitation wavelength) and 590 nm (emission 
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wavelength) in a SpectraMax GEMINI EM microplate 
reader (Molecular Devices).
SiRNA-transfected cells (MCF-7) were seeded into 
96-well plates (2 × 103 cells/well) at day 5 post-transfection. 
48 h after seeding, cells were exposed to increasing doses 
of 5-fluoro-2′-deoxyuridine (5-FdUrd) (0-1 μM) (Sigma-
Aldrich) for 24 h. For thymidine (dThd) supplementation, 
siRNA-transfected cells were seeded at day 5 post-transfec-
tion and 5 μM of dThd was added to the culture medium 
and renewed every 24 h. The relative population doubling 
(RPD) was calculated as PDtreated/PDuntreated × 100%, 
where PD = {log [N24h/N0]}/log 2 [50].
Cell cycle analysis by fluorescence‑activated cell 
sorting (FACS)
For cell cycle analysis, cells were pulse labeled with 10 µM 
BrdU (Becton–Dickinson) for 1 h at 37 °C. After BrdU incu-
bation, cells were trypsinized, washed with 1 × PBS and then 
fixed and permeabilized with 70% ice-cold ethanol over-
night. After fixation, cells were washed (1 × PBS and 0.2% 
Tween 20), incubated 20 min with 4 M HCl and 1% Triton 
X-100, washed three times and then incubated at 4 °C over-
night with anti-BrdU-FITC antibody (Becton–Dickinson) 
diluted 1:5 in 1% Blocking Reagent (Roche). For DNA stain-
ing, cells were incubated with 0.05 mg/mL of propidium 
iodide and 0.05 mg/mL of RNAse at room temperature for 
20 min. Finally, cells were analyzed using a FACSAria III 
cell sorter flow cytometer (Becton–Dickinson). Data were 
evaluated using FlowJo cell analysis software.
Immunoblotting and antibodies
Cell pellets were incubated with RIPA buffer (25  mM 
Tris:HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium 
deoxycholate, 0.1% SDS) (Sigma-Aldrich), containing 
1 × Halt Protease/Phosphatase Inhibitors (Thermo-Fisher 
Scientific) and incubated 10 min on ice. Lysates were cen-
trifuged at 14,000g for 15 min at 4 °C and the supernatant 
stored at − 20 °C. Extracts were mixed with SDS-loading 
buffer, boiled, electrophoresed and transferred to PVDF 
membranes. Primary antibodies were incubated at 4 °C 
overnight.
The antibodies anti-DCTPP1 and anti-dUTPase are 
anti-rabbit polyclonal antibodies generated in our labora-
tory [10, 11]. Antibodies directed against TK1 (C-4), dCK 
(H-3), DCTD (F-9), TMPK (B-8), TS (H-265) and R2 (A-5) 
were obtained from Santa Cruz; p53R2 (Sigma-Aldrich); 
SAMHD1 (ABIN3187981) from Antibodies Online; TK2 
(Acris); pChk2-Thr68 (C13C1) and pChk1-Ser345 (133D3) 
from Cell Signaling technology; CTPS1 (Abcam); α-tubulin 
(B-5-1-2) and actin (MM2/193) from Sigma-Aldrich and 
anti-UNG (GeneTex).
dNTP pool size determination
Briefly, 2.2 × 106 cells were extracted with 1.2 mL of 1:1 
(v:v) methanol/water at − 20 °C and the suspension was vor-
tex mixed. Samples were then subjected to two freeze–thaw 
cycles (10 min each at dry ice/ethanol) and then centrifuged 
at 16,000g for 20 min and 4 °C. The supernatants were col-
lected, split into three 250 µL aliquots for the determina-
tion of dCTP, dTTP, dUTP and dGTP and stored at − 80 °C. 
Samples were dried under vacuum and then dissolved in 
40 µL of buffer (34 mM Tris/HCl pH 7.8 and 5 mM  MgCl2) 
with or without 30 ng of dUTPase and incubated for 20 min 
at 37 °C. The reaction was stopped with 100% of cold meth-
anol and centrifuged at 16,000g for 20 min at 4 °C, dried and 
used for the quantification of the dNTP pool as previously 
described [10].
Determination of uracil in DNA
The incorporation of uracil into genomic DNA was deter-
mined using a quantitative real-time PCR-based assay fol-
lowing the protocol described [20, 51]. Briefly, genomic 
DNA was extracted and digested with SacI-HF (New Eng-
land Biolabs), and 3–5 kb fragments containing the target 
template, GAPDH gene, were isolated and purified from 1% 
agarose gel. A series of twofold dilutions was amplified with 
PfuTurbo Hotstart (Agilent Technologies) or Taq (Bioline) 
DNA polymerases as previously described [11]. All values 
refer to wild-type or control siRNA-transfected cells.
Immunofluorescence analysis
For γH2AX foci analysis, cells were first seeded on ster-
ile glass coverslips in 12-well plates. Cells were fixed and 
permeabilized as previously described [11], incubated with 
1:400 diluted polyclonal anti-γH2AX antibody (Abcam) and 
detected with secondary Alex  Fluor® 488-conjugated goat 
anti-mouse IgG (Life Technologies). For EdU staining, cells 
were pulse labeled with 10 μM EdU (Invitrogen) prior to cell 
fixation. EdU incorporation was detected with the Click-
iT® EdU  AlexaFluor® 594 imaging kit (Invitrogen). Digital 
images were captured using a LEICA TCS SP5 confocal 
microscopy system and analyzed using Fiji software.
To visualize DCTPP1, HAP1 WT and DCTPP1-KO, cells 
were grown on sterile glass coverslips. For mitochondrial 
labeling, cells were incubated with 250 nM of MitoTrack-
erTM Red CMX Ros (Invitrogen) for 30 min at 37 °C. Fixa-
tion, permeabilization and blocking were performed as pre-
viously described. Cell were incubated with anti-DCTPP1 at 
a 1:1000 dilution for 1 h, washed and incubated with Alexa 
 Fluor® 488-conjugated anti-rabbit secondary antibody. Digi-
tal images were captured using a LEICA TCS SP5 confocal 
microscopy system.
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Quantification of anaphase bridges
MCF-7 cells were seeded on sterile glass coverslips and syn-
chronized at G2/M by incubation with 50 ng/µL of nocoda-
zole (Sigma-Aldrich) for 18 h. Cells were then incubated 
in normal MEM medium for 90 additional minutes before 
being fixed and DAPI stained. Digital images were captured 
using a LEICA TCS SP5 confocal microscopy system.
Hypoxanthine‑guanine phosphoribosyltransferase 
(HPRT) mutation assay
HAP1 WT and DCTPP1-KO cell lines were initially grown 
for 3 days in IMDM complete medium supplemented with 
1  ×  HAT (hypoxanthine–aminopterin–thymidine) (Life 
Technologies). HPRT-null pre-existing mutants were 
removed by blocking de novo purine biosynthesis with ami-
nopterin. Following HAT treatment, cells were incubated 
with HT (hypoxanthine–thymidine) (Life Technologies) for 
24 h to restore de novo metabolism. Cells were passaged 
every 2–3 days and grown for 14 days prior to 6-thiogua-
nine (6-TG) (Sigma-Aldrich) selection to fix spontaneous 
 HPRT− mutations. Cells were then seeded into 96-well 
plates (10,000 cells/well) and grown for 14 days in the pres-
ence of 2 µM 6-TG, which was renewed every 2–3 days. 
To determine plating efficiency, 1 cell/well was seeded into 
a 96-well plate, in non-selective medium and grown for 
14 days. After 6-TG selection, colonies were fixed with a 
3:1 methanol:acetic acid solution and stained with a solu-
tion of 0.5% of crystal violet in methanol. Plating efficiency 
and mutation frequencies were determined as previously 
described [28].
Chloramphenicol resistance assay
Chloramphenicol (CAP) resistance was determined as a 
measure of mtDNA mutagenesis. HAP1 WT and DCTPP1-
KO cells were seeded onto six-well dishes at 300 cells/well. 
24 h after seeding, 300 µg/mL of CAP (Sigma-Aldrich) was 
added to each well and cells were grown in CAP-containing 
medium for 7 more days. To determine the plating efficiency, 
the same number of cells were seeded and cultured in the 
absence of CAP. Cells were allowed to grow for 7 more days 
after CAP treatment and then fixed with methanol:acetic acid 
(3:1 v/v) for 5 min and stained with 0.5% crystal violet solu-
tion. Colonies were counted using an optical microscope. 
The proportion of CAP-resistant colonies was calculated by 
dividing the number of colonies formed after CAP treatment 
by the number of colonies formed in the absence of CAP.
Statistics
Student’s t test was used to compare different sets of data. 
Two-way ANOVA was used to analyze normally distributed 
data, followed by Dunnett’s post hoc test. Statistics were 
calculated with IBM SPSS Statistics or GraphPad Prism 5. 
Results are expressed as mean ± SD of at least three inde-
pendent experiments. *P < 0.05, **P < 0.01, ***P < 0.001.
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